Pro-Dex IncPDEX
Price$65.36Intrinsic value$44.2032% below price

Valuation

How Intrinsic Value compares with model outputs

Intrinsic Value $44.20median of 6 methods · middle span $31-$72based on filings through 31 Mar 2026
Market Price $65.36Price as of 1 Oct 2026
Margin of Safety -32.4%as of 1 Oct 2026

Valuation methods vs. Market Price

Company vs. peer median Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions

ParameterValue
Years 1–5: analyst growth pathFive-year total matches analyst consensus exactly. Year 1: 5.0% (near-term consensus, capped) · years 2–5: 5.0%/yr (balance of the path).5.0% per year
Years 6–10: glide to demonstrated growth own history 21.3%, capped at 20%
Per-year rates
Yr 65.0%Yr 75.0%Yr 85.0%Yr 95.0%Yr 105.0%
5.0% → 5.0%
Years 11–20: glide to long-run rate
Per-year rates
Yr 114.8%Yr 124.6%Yr 134.4%Yr 144.2%Yr 154.0%Yr 163.8%Yr 173.6%Yr 183.4%Yr 193.2%Yr 203.0%
5.0% → 3.0%
Beyond year 20: terminal growthPerpetual long-run rate3.0%
Historical EPS growth (multi-year median)median of 3 windows (5/6/7y)21.3%
Discount rate (cost of equity) 6.7%
Volatility vs market (adjusted beta)0.38

Valuation Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions Sandbox Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Compare with peers

Search any company to compare valuation, profitability, returns, growth, and financial strength side by side.

Compare the target company plus 1 peer. Sign in / Sign up to compare a maximum of 3 peers.

Best in rowHigher is betterLower is better—Data not available
TargetPro-Dex IncPDEXHealth Care
Valuation
P/E15.9×
P/S3.0×
P/B5.1×
EV / Revenue3.1×
EV / EBITDA11.8×
Profitability
Gross margin31.0%
Operating margin15.6%
Net margin17.6%
FCF margin8.7%
Returns
ROE28.7%
ROA18.3%
ROIC24.0%
Growth
Revenue growth (YoY)16.5%
5-yr fwd EPS growth—
Financial strength
Debt / Equity0.37×
Current ratio4.10×
Altman Z-Score8.3
Interest coverage—
Dividend yield—

Best value in each row is highlighted. Figures are periodic snapshots from the same filings used across each dossier; a dash means the figure is not available.

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.